ChronoScale Corporation Common Stock (NASDAQ:CHRN) Share Price Crosses Above 50-Day Moving Average – Here’s Why

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $13.84 and traded as high as $17.66. ChronoScale Corporation Common Stock shares last traded at $17.41, with a volume of 402,143 shares changing hands.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research report on Friday, March 27th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, ChronoScale Corporation Common Stock has a consensus rating of “Reduce” and an average price target of $6.00.

ChronoScale Corporation Common Stock Stock Up 1.0%

The firm’s 50 day simple moving average is $13.84 and its 200 day simple moving average is $10.33. The company has a market cap of $61.98 million, a price-to-earnings ratio of -3.24 and a beta of 1.02. The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its quarterly earnings data on Tuesday, April 28th. The company reported ($2.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($2.01). The company had revenue of $2.14 million during the quarter, compared to the consensus estimate of $4.29 million. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. Sell-side analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Roble Belko & Company Inc raised its holdings in ChronoScale Corporation Common Stock by 104.5% in the 1st quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock worth $25,000 after acquiring an additional 1,195 shares during the period. Virtu Financial LLC bought a new position in ChronoScale Corporation Common Stock in the 3rd quarter worth $57,000. Shay Capital LLC bought a new position in ChronoScale Corporation Common Stock in the 3rd quarter worth $67,000. Citadel Advisors LLC bought a new position in ChronoScale Corporation Common Stock in the 3rd quarter worth $198,000. Finally, Geode Capital Management LLC raised its holdings in ChronoScale Corporation Common Stock by 68.9% in the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after acquiring an additional 10,281 shares during the period. Institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.